BioCentury
ARTICLE | Clinical News

Xigduo XR dapagliflozin/metformin extended-release regulatory update

November 10, 2014 8:00 AM UTC

FDA approved once-daily Xigduo XR dapagliflozin/metformin extended-release tablets to treat Type II diabetes. The extended-release combination of dapagliflozin, a sodium-glucose cotransporter 2 (SGLT...